Literature DB >> 33834610

Reinforced electrospun nanofiber composites for drug delivery applications.

Neelima Anup1, Tejas Chavan1, Shruti Chavan1, Suryanarayana Polaka1, Dnyaneshwar Kalyane1, Sara Nidal Abed2, Katharigatta N Venugopala3,4, Kiran Kalia1, Rakesh K Tekade1.   

Abstract

Electrospun technology becomes a valuable means of fabricating functional polymeric nanofibers with distinctive morphological properties for drug delivery applications. Nanofibers are prepared from the polymer solution, which allows the direct incorporation of therapeutics such as small drug molecules, genes, and proteins by merely mixing them into the polymeric solution. Due to their biocompatibility, adhesiveness, sterility, and efficiency in delivering diverse cargoes, electrospun nanofibers have gained much attention. This review discusses the capabilities of the electrospun nanofibers in delivering different therapeutics like small molecules, genes, and proteins to their desired target site for treating various ailments. The potential of nanofibers in administering through multiple administration routes and the associated challenges has also been expounded along with a cross-talk about the commercial products of nanofibers for biomedical applications.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  drug delivery; electrospinning; nanofiber composite; therapeutics

Mesh:

Substances:

Year:  2021        PMID: 33834610     DOI: 10.1002/jbm.a.37187

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  2 in total

Review 1.  Electrospun-Fibrous-Architecture-Mediated Non-Viral Gene Therapy Drug Delivery in Regenerative Medicine.

Authors:  Elena Cojocaru; Jana Ghitman; Raluca Stan
Journal:  Polymers (Basel)       Date:  2022-06-29       Impact factor: 4.967

Review 2.  Progress Report: Antimicrobial Drug Discovery in the Resistance Era.

Authors:  Pottathil Shinu; Abdulaziz K Al Mouslem; Anroop B Nair; Katharigatta N Venugopala; Mahesh Attimarad; Varsha A Singh; Sreeharsha Nagaraja; Ghallab Alotaibi; Pran Kishore Deb
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.